Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Palatability evaluation of carbocisteine oral solutions in children
ChiCTR2100041778Phase 4Completed
- Sponsor
- Beijing Children's Hospital
- Start
- Dec 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of carbocisteine in bronchitis and asthma (2 arms), sponsored by Beijing Children's Hospital. Primary endpoint: palatability. Started Dec 2020; status: completed.
02
Drugs
carbocisteine
03
Conditions
bronchitisasthma
Beyond the preview
Go deeper on ChiCTR2100041778.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100041778.